Document Detail

Urinary angiotensinogen and risk of severe AKI.
MedLine Citation:
PMID:  23143504     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Biomarkers of AKI that can predict which patients will develop severe renal disease at the time of diagnosis will facilitate timely intervention in populations at risk of adverse outcomes.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Liquid chromatography/tandem mass spectrometry was used to identify 30 potential prognostic urinary biomarkers of severe AKI in a group of patients that developed AKI after cardiac surgery. Angiotensinogen had the best discriminative characteristics. Urinary angiotensinogen was subsequently measured by ELISA and its prognostic predictive power was verified in 97 patients who underwent cardiac surgery between August 1, 2008 and October 6, 2011.
RESULTS: The urine angiotensinogen/creatinine ratio (uAnCR) predicted worsening of AKI, Acute Kidney Injury Network (AKIN) stage 3, need for renal replacement therapy, discharge >7 days from sample collection, and composite outcomes of AKIN stage 2 or 3, AKIN stage 3 or death, and renal replacement therapy or death. The prognostic predictive power of uAnCR was improved when only patients classified as AKIN stage 1 at the time of urine sample collection (n=79) were used in the analysis, among whom it predicted development of stage 3 AKI or death with an area under the curve of 0.81. Finally, category free net reclassification improvement showed that the addition of uAnCR to a clinical model to predict worsening of AKI improved the predictive power.
CONCLUSIONS: Elevated uAnCR is associated with adverse outcomes in patients with AKI. These data are the first to demonstrate the utility of angiotensinogen as a prognostic biomarker of AKI after cardiac surgery.
Joseph L Alge; Nithin Karakala; Benjamin A Neely; Michael G Janech; James A Tumlin; Lakhmir S Chawla; Andrew D Shaw; John M Arthur;
Related Documents :
24821464 - Endoscopic bilio-duodenal bypass: outcomes of primary and revision efficacy of combined...
19337484 - The effect of an intravitreal triamcinolone acetonide injection for acute nonarteritic ...
23043034 - Gore helex septal occluder for percutaneous closure of patent foramen ovale associated ...
25325064 - Comparison of semilunar coronally repositioned flap with gingival massaging using an ay...
23109694 - Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction re...
24986744 - A prospective quasi-randomized comparison of intraoperatively built custom-linked seeds...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2012-11-08
Journal Detail:
Title:  Clinical journal of the American Society of Nephrology : CJASN     Volume:  8     ISSN:  1555-905X     ISO Abbreviation:  Clin J Am Soc Nephrol     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-02-08     Completed Date:  2013-08-12     Revised Date:  2014-02-14    
Medline Journal Info:
Nlm Unique ID:  101271570     Medline TA:  Clin J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  184-93     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Kidney Injury / epidemiology,  urine*
Angiotensinogen / urine*
Biological Markers / urine
Middle Aged
Severity of Illness Index
Grant Support
Reg. No./Substance:
0/Biological Markers; 11002-13-4/Angiotensinogen
Juan Carlos Q Velez / ; Elizabeth G Hill / ; Milos N Budisavljevic / ; Rick G Schnellmann / ; Frederick T Josh Billings /

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.
Next Document:  Clival giant cell tumor presenting with isolated trigeminal nerve involvement.